Stockscreener 앱 받기
1.67
4.02%
-0.07
전일 마감가:
$1.74
열려 있는:
$1.69
하루 거래량:
77,256
Relative Volume:
0.00
시가총액:
$2.40M
수익:
$6.63M
순이익/손실:
$-4.06M
주가수익비율:
-0.3025
EPS:
-5.5206
순현금흐름:
$-4.20M
1주 성능:
-21.23%
1개월 성능:
-39.05%
6개월 성능:
-70.20%
1년 성능:
-77.96%
1일 변동 폭
$1.62
$1.7497
1주일 범위
$1.6074
$2.24
52주 변동 폭
$1.6074
$19.70
Bio Key International Inc Stock (BKYI) Company Profile
명칭
Bio Key International Inc
전화
(732) 359-1100
주소
101 CRAWFORDS CORNER RD, HOLMDEL
Compare BKYI vs ALLE, MSA, ADT, BCO, GEO
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BKYI
Bio Key International Inc
|
1.67 | 2.40M | 6.63M | -4.06M | -4.20M | -5.5206 |
ALLE
Allegion Plc
|
150.48 | 12.80B | 4.16B | 633.70M | 704.08M | 7.3243 |
MSA
Msa Safety Inc
|
180.71 | 6.97B | 1.92B | 290.57M | 309.48M | 7.4089 |
ADT
Adt Inc
|
6.43 | 4.70B | 5.14B | 627.10M | 1.50B | 0.7058 |
BCO
Brinks Co
|
103.40 | 4.26B | 5.39B | 191.50M | 544.10M | 4.2833 |
GEO
Geo Group Inc
|
31.13 | 4.10B | 2.73B | 273.07M | -30.60M | 1.9669 |
Bio Key International Inc Stock (BKYI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-26 | 업그레이드 | Maxim Group | Hold → Buy |
Bio Key International Inc 주식(BKYI)의 최신 뉴스
A vote on warrant shares remains open as BIO-key (BKYI) plans to reconvene its meeting October 30. - Stock Titan
BIO-key International Retires Streeterville Note Via Debt-for-Equity Exchange, Issuing 247,805 Shares - TradingView
Why BIO-key International (BKYI) Stock Is Up Today - Quiver Quantitative
BKYI Stock Jumps As FIDO Certification Fuels Passwordless Hype - timothysykes.com
BKYI Stock Jumps As FIDO Certification Fuels Passwordless Hype - Timothy Sykes
These stocks that are showing activity before the opening bell on Tuesday. - ChartMill
BIO-key Partners with Al Majlis Group to Expand Identity Security Across Arabian Gulf - GlobeNewswire Inc.
BIO-key (BKYI) Slides Another -3.64% — Relief Rally Falters 2026-09-22Gap and Go - siam.in
BIO-key adjourns annual meeting over warrant share vote - TipRanks
BKYI: Biometric IAM platform accelerates growth amid regulatory demand and global deployments - TradingView
BIO-key to Reconvene Annual Meeting After Insufficient Votes on Warrant Approval - TradingView
Shareholder vote on 1.24M new shares delayed at BIO-key (NASDAQ: BKYI) - Stock Titan
BIO-Key International Inc (BKYI) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
BIO-key International CEO to Participate in Virtual Meetings at H.C. Wainwright’s 28th Annual Global Investment Conference - Quiver Quantitative
BIO-key to Meet Investors at H.C. Wainwright | BKYI Stock News - Stock Titan
BIO-Key International Inc (BKYI) Peer Comparison – Compare with Others - Value Research
BIO-Key International Inc (BKYI) Key Financial Ratios – Valuation, Profitability & More - Value Research
BIO-key (BKYI) Q2 2026 Earnings Call Transcript - The Globe and Mail
BIO-key (BKYI) Q2 2026 Earnings Call Transcript - The Globe and Mail
KALA BIO: Q2 Earnings Snapshot - AOL.com
BIO-key International (BKYI)Conferencia de resultados del T2 de 2026: margen bruto del 87 %, objetivo de rentabilidad para el segundo semestre - TradingKey
BIO-key partners with Central Bank of Jordan to modernize authentication - scanx.trade
BIO-key International (BKYI) Teleconferência de Resultados do T2 de 2026: Margem Bruta de 87%, Meta de Lucratividade para o Segundo Semestre - TradingKey
BIO-key International Inc (BKYI) (Q2 2026) Earnings Call Highlig - GuruFocus
BIO-key International Inc (BKYI) (Q2 2026) Earnings Call Highlig - GuruFocus
BIO-key International (BKYI) asks investors to approve 1.24M-share warrant issuance - Stock Titan
BIO-key International | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
BKYI Q2 FY2026 earnings call - finance.biggo.com
BIO-key International (BKYI) Q2 2026 Earnings Call: 87 % Bruttomarge, Profitabilitätsziel für das zweite Halbjahr - TradingKey
BIO-key International (BKYI) Q2 2026 Earnings Call: 87% Gross Margin, Second-Half Profitability Target - TradingKey
BIO-key International Reports Narrower Loss for Q2 FY26; Revenue up 13% - AlphaStreet
BKYI: Record gross margin and strong EMEA growth drive improved results and positive H2 outlook - TradingView
Earnings call transcript: BIO-key beats q2 2026 EPS but misses revenue as shares fall - Investing.com Australia
Earnings call transcript: BIO-key beats q2 2026 EPS but misses revenue as shares fall - Investing.com Nigeria
BKYI: Q2 2026 delivered strong margin gains and revenue growth, with profitability targeted for H2 - TradingView
Earnings call transcript: BIO-key beats q2 2026 EPS but misses revenue as shares fall - Investing.com
BIO-key International Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
BIO-key International Releases Q2 2026 Financial Results - AlphaStreet
Form 8K BIO-Key International Inc For: 14 August By Investing.com - Investing.com Australia
BIO-key International, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Form 8K BIO-Key International Inc For: 14 August By Investing.com - Investing.com Nigeria
Form 8K BIO-Key International Inc For: 14 August By Investing.com - Investing.com Canada
Form 8K BIO-Key International Inc For: 14 August By Investing.com - Investing.com UK
BIO-key Q2 Revenue Rises 13% as Net Loss Narrows 51% - Quiver Quantitative
BIO Key International Q2’26: Revenues up 13% to $1.92M; net loss narrowed 51% - TradingView
BIO-key International (NASDAQ: BKYI) grows Q2 sales and cuts loss sharply - Stock Titan
BIO-key Q2 Loss Narrows to $576,852 Despite Cash Reserve Decline - Minichart
BKYI Looks 49.6% Overvalued on GF Value™ - GuruFocus
BIO-key International Q2 2026 Earnings Call Transcript - MarketBeat
BKYI: Q2'26 revenue up 13%, net loss down 51%, with strong EMEA growth and improved margins - TradingView
Bio Key International Inc (BKYI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.54%
7.08%
자본화:
|
볼륨(24시간):